Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Penney

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Annals of Neurology|May 1, 1977
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapyK H Rand, K P Johnson, L J Rubinstein, et al.
Neurology|February 11, 2000
Rate of functional decline in Huntington's disease. Huntington Study GroupK Marder, H Zhao, R H Myers, et al.
Annals of Neurology|April 11, 1992
Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's diseaseR L Albin, A Reiner, K D Anderson, et al.
The Journal of Comparative Neurology|November 2, 1999
Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal gangliaC M Kosinski, S Risso Bradley, P J Conn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 1998
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2L Yang, R T Matthews, J B Schulz, et al.
Archives of Neurology|January 1, 1995
Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's diseaseB Giordani, S Berent, M J Boivin, et al.
Neurology|February 1, 1986
Huntington's disease in Venezuela: neurologic features and functional declineA B Young, I Shoulson, J B Penney, et al.
Neurobiology of Disease|January 1, 1997
Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellumC R Scherzer, G B Landwehrmeyer, J A Kerner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individualsJ B Penney, A B Young, I Shoulson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease geneJ H Cha, C M Kosinski, J A Kerner, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Annals of Neurology|May 1, 1977
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapyK H Rand, K P Johnson, L J Rubinstein, et al.
Neurology|February 11, 2000
Rate of functional decline in Huntington's disease. Huntington Study GroupK Marder, H Zhao, R H Myers, et al.
Annals of Neurology|April 11, 1992
Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's diseaseR L Albin, A Reiner, K D Anderson, et al.
The Journal of Comparative Neurology|November 2, 1999
Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal gangliaC M Kosinski, S Risso Bradley, P J Conn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 1998
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2L Yang, R T Matthews, J B Schulz, et al.
Archives of Neurology|January 1, 1995
Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's diseaseB Giordani, S Berent, M J Boivin, et al.
Neurology|February 1, 1986
Huntington's disease in Venezuela: neurologic features and functional declineA B Young, I Shoulson, J B Penney, et al.
Neurobiology of Disease|January 1, 1997
Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellumC R Scherzer, G B Landwehrmeyer, J A Kerner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individualsJ B Penney, A B Young, I Shoulson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease geneJ H Cha, C M Kosinski, J A Kerner, et al.
Pageof 15